
Monday, May 14, 2007

|
The BioAnalytics Group
A Software and Service Company in the BioMedical
Research Market

About

|
The BioAnalytics Group offers software products and services to the biomedical research industry. Targets are academic & government research groups, pharmaceutical & biotechnology companies, and laboratory & clinical device developers. Customers include Novartis, Roche, Princeton University, Mt. Sinai School of Medicine, University of Arizona Cancer Center, Ventana Medical Systems, and the National Institutes of Health.
BioPathwise DM™ is a data management system for researchers that simplifies capture, sharing, and protection of laboratory data in any format, from any device. Its extensible architecture permits advanced data analysis and visualization modules for specific devices. Modules for digital microscopy and quantitative PCR devices are available.
The primary market is the individual biomedical research group within academic, pharmaceutical and biotechnology laboratories. In addition to this end-user market, the company seeks to license BioPathwise DM to medical device and laboratory instrument manufacturers to integrate with their hardware and consumables products.
The company is considering options to finance marketing and sales of its commercial products.

3 Major Issues

|
- How do we best reach our audience of research groups within academic laboratories, pharmaceutical and biotechnology companies, and device developers?
- What are the strategic options for growing the BioPathwise DM licensing market?
- What level and modes of financing should we consider to support our sales and marketing efforts and further develop BioPathwise DM?

Program:

|
6:30 - Cocktails & Dinner (Cash bar and special 2-entree buffet menu)
8:00 -G. Scott Lett, CEO of The BioAnalytics Group will deliver the company’s “Elevator Pitch”
8:20 - Panel addresses 3 major issues for The BioAnalytics Group
9:00 - Open discussion: members and guests
<Top of the page>
|
 |
 |

Slides
None available at this time

Audio
None available at this time

Video
None available at this time

Webcast
None available at this time

|

|
|